Can manipulation of a pelvic tumour influence the serum level of cancer antigen 125 and cancer-associated serum antigen?

British Journal of Cancer

Volumn 77, Issue 11, 1998, Pages 2012-2013

  Kierkegaard, O ^a,c   Mogensen, O ^b   Mogensen, B ^b   Ahrons, S ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^c NONE   (Denmark)

Author keywords

CA 125; CASA; Tumour associated antigen; Ultrasonography

Indexed keywords

CA 125 ANTIGEN; TUMOR ANTIGEN;

ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; PELVIS TUMOR; PRIORITY JOURNAL; SERUM;

EID: 0031801372     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.334     Document Type: Article

References (6)

1. Kierkegaard O, Mogensen O, Mogensen B and Jakobsen A (1995) Predictive and prognostic values of cancer-associated serum antigen (CASA) and cancer antigen 125 (CA 125) levels prior to second-look laparotomy for ovarian cancer. Gynecol Oncol 59: 251-254
2. Kobayashi F, Sagawan N, Nakamura K, Nonogaki M, Ban C, Fujii S and Mori T (1989) Mechanism and clinical significance of elevated CA 125 levels in the sera of pregnant women. Am J Obstet Gynecol 160: 563-566
3. Lehtovirta P, Apter D and Stenman UH (1990) Serum CA 125 levels during the menstrual cycle. Br J Obstet Gynaecol 97: 930-933
4. R CA 125™, an automated microparticle enzyme immunoassay: technical characteristics and clinical usefulness after recalibration. Scand J Clin Lab Invest 55: 289-294
5. Mogensen O, Brock A and Nyland MH (1993) CA 125 measurements in ovarian cancer patients during their first postoperative week. Int J Gynecol Cancer 3: 54-56
6. Van Der Zee AGJ, Duk JM, Aalders JG, Boontje AH, Ten Hoor KA and Bruijn HWA (1990) The effect of abdominal surgery on the serum concentration of the tumour-associated antigen CA 125. Br J Obstet Gynaecol 97: 934-938